| 1950 |
- Hitachi Chemical Co., Ltd. (as Chemiphar was formerly known) is set up
- Taiichiro Yamaguchi is president
|
| 1951 |
- Hatagaya Factory opens in Shibuya-ku, Tokyo
|
| 1953 |
- Akira Yamaguchi assumes post of president
|
| 1957 |
- Starts importing pharmaceuticals from Italy
- Main office moves to Bunkyo-ku Tokyo
|
| 1960 |
- Soka Factory opens in Misato City, Saitama Prefecture
|
| 1970 |
- Company changes name to Nippon Chemiphar Co., Ltd.
- Distribution center opens in Toda City, Saitama Prefecture
- Nihon Pharmaceutical Industry Co., Ltd. (NPI) becomes a subsidiary
|
| 1971 |
- Listed on Tokyo Stock Exchange (Second Section)
|
| 1973 |
- Establishes R&D facility in Misato City, Saitama Prefecture
|
| 1974 |
- Establishes DC meeting (for presidents of wholesalers)
|
| 1975 |
- Head office moved to Chiyoda-ku, Tokyo
|
| 1976 |
- Listed on Tokyo Stock Exchange (First Section)
- Starts diagnostics business
- Establishes Japan Sopharchim Co., Ltd. (currently an affiliated company)
|
| 1977 |
- Establishes Ibaraki Factory (NPI's current Tsukuba Factory) in Makabe-gun, Ibaraki Prefecture
|
| 1982 |
- Keizo Ushiyama becomes president
|
| 1983 |
- Establishes Shapro Inc. (currently a consolidated subsidiary), enters cosmetics and health-food market
|
| 1986 |
- Safety Research Institute for Chemical Compounds Co., Ltd. becomes a subsidiary
|
| 1988 |
- Launches Uralyt-U (soluble powder)
|
| 1990 |
- Harufumi Nakamura becomes president
|
| 1992 |
|
| 1993 |
|
| 1994 |
- Kazushiro Yamaguchi becomes president
|
| 1995 |
|
| 1998 |
- Launches Calvan Tab. in South Korea
|
| 1999 |
- Launches Soleton Tab. 80 in South Korea
|
| 2001 |
- Launches DiaPack2000 and Oriton IgE Chemiphar
|
| 2002 |
- Comprehensive business alliance concluded with Ranbaxy Laboratories Limited in India
- Ibaraki Factory (NPI's current Tsukuba Factory) acquires ISO14001 certification
|
| 2003 |
- Pravastan Tab,a potential mega generic,is launched in July
|
| 2004 |
- Allocation of new shares to Nihon Chouzai Co., Ltd.; Chemiphar concludes business alliance with Nihon Chouzai Co., Ltd.
|
| 2005 |
- A subsidiary company, NPI, becomes 50:50 joint venture of Chemiphar and Ranbaxy
- PPAR delta agonist and NC-2300 are licensed out to overseas venture companies
- Accumulated consolidated loss cleared in interim period of fiscal year ended March 2006
|
| 2007 |
- Start of medium-term management plan focusing on generic pharmaceuticals
|
| 2008 |
- Amlodipine Chemiphar,a potential mega generic,is launched in July
|
| 2009 |
- Dissolves the comprehensive business alliance with Ranbaxy. NPI becomes a subsidiary again.
|
| 2010 |
- NPI becomes a wholly owned Chemiphar subsidiary;.Chemiphar spins off its Ibaraki Factory to NPI.
- Termination of business alliance with Nihon Chouzai Co., Ltd.
|
